Skip to main content

Table 7 Comparison of Samara DOTS cohort with overall treatment success and outcome for global DOTS cohorts in 2002

From: The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation

%

Died

Failed

Defaulted

Treatment success

Samara, Russia

3.6

2.2

5.1

75.3

Eastern Europe

6.7

8.8

6.4

74.9

Central europe

5.0

3.5

6.0

79.7

East Mediterranean

3.2

1.4

7.8

83.5

Established markets

9.7

2.4

2.6

76.5

Latin America

4.3

1.2

6.0

83.4

Southeast asia

3.9

2.5

6.4

85.1

Western Pacific

2.2

0.9

2.2

89.1

  1. Established markets include member states of the EU, North America, Australia, New Zealand and Japan.